Lifex BioLabs, Inc
NTU scientists discover potential treatment for Parkinson’s disease
Scientists from Singapore’s Nanyang Technological University (NTU Singapore) and McLean Hospital and Harvard Medical School in the United States have found that existing anti-malaria drugs could be a potential treatment for Parkinson’s disease.
PGE1 and PGA1 bind to Nurr1 and activate its transcriptional function.
The orphan nuclear receptor Nurr1 is critical for the development, maintenance and protection of midbrain dopaminergic (mDA) neurons. Here we show that prostaglandin E1 (PGE1) and its dehydrated metabolite, PGA1, directly..,